» Recombinant DNA (rDNA)

Recombinant DNA (rDNA)

1973
  • Stanley Norman Cohen
  • Herbert Boyer

Recombinant DNA (rDNA) technology involves joining together DNA molecules from two different species. The recombinant DNA is inserted into a host organism to produce new genetic combinations. This is achieved using restriction enzymes to cut DNA at specific sites and DNA ligase to join the fragments, often incorporating the desired gene into a plasmid vector for cloning.

Recombinant DNA technology, also known as genetic engineering, is the process of creating artificial DNA by combining genetic material from different sources. This technology fundamentally changed biology and medicine by allowing scientists to directly manipulate the genetic code of organisms. The core procedure involves several key steps. First, a gene of interest is identified and isolated from a source organism’s DNA. This is often done using restriction enzymes, which are proteins that act like molecular scissors, cutting DNA at specific recognition sequences. Second, a vector, which is a DNA molecule used to carry the foreign genetic material into another cell, is chosen. Bacterial plasmids—small, circular DNA molecules separate from the bacterial chromosome—are the most common vectors. The same restriction enzyme used to cut out the gene is used to cut open the plasmid vector. This creates compatible ‘sticky ends’ on both the gene and the plasmid. Third, the isolated gene is inserted into the plasmid. The sticky ends of the gene anneal with the complementary sticky ends of the plasmid, and the enzyme DNA ligase is added to permanently join them by forming phosphodiester bonds. The resulting molecule is a recombinant plasmid containing the new gene. Finally, this recombinant vector is introduced into a host organism, typically a bacterium like *E. coli*, through a process called transformation. As the host cells multiply, they replicate the recombinant plasmid along with their own DNA, creating many copies of the inserted gene. The host cells can also transcribe and translate the foreign gene to produce the desired protein, such as human insulin produced in bacteria.

UNESCO Nomenclature: 2406
– Molecular Biology

类型

化学工艺

中断

革命

使用方法

广泛使用

前体

  • discovery of DNA as genetic material
  • elucidation of the DNA double helix structure
  • discovery of plasmids in bacteria
  • discovery and characterization of restriction enzymes by Werner Arber, Daniel Nathans, and Hamilton Smith
  • discovery of DNA ligase

应用

  • production of synthetic human insulin for diabetics
  • creation of genetically modified organisms (GMOs)
  • production of vaccines (e.g., hepatitis B vaccine)
  • gene therapy
  • production of clotting factors for hemophilia

专利:

  • US4237224

潜在的创新想法

级别需要会员

您必须是!!等级!!会员才能访问此内容。

立即加入

已经是会员? 在此登录
Related to: recombinant DNA, genetic engineering, stanley cohen, herbert boyer, plasmid, vector, restriction enzyme, DNA ligase, gene cloning, GMO.

发表回复

您的邮箱地址不会被公开。 必填项已用 * 标注

迎接新挑战
机械工程师、项目、工艺工程师或研发经理
有效的产品开发

可在短时间内接受新的挑战。
通过 LinkedIn 联系我
塑料金属电子集成、成本设计、GMP、人体工程学、中高容量设备和耗材、精益制造、受监管行业、CE 和 FDA、CAD、Solidworks、精益西格玛黑带、医疗 ISO 13485

我们正在寻找新的赞助商

 

您的公司或机构从事技术、科学或研究吗?
> 给我们发送消息 <

接收所有新文章
免费,无垃圾邮件,电子邮件不分发也不转售

或者您可以免费获得完整会员资格以访问所有受限制的内容>这里<

相关发明、创新和技术原理

滚动至顶部

你可能还喜欢